In pancreatic cancer, extensive MLH1 expression was significantly associated with favorable differentiation and less lymph node metastasis, and univariate analysis showed that patients with low expression of MLH1 in tumor tissues had significantly poorer overall survival [32]. This evidence concerns the gene MLH1 and metastatic malignant neoplasm in the lymph nodes.